Page last updated: 2024-10-20

pyrazinamide and Muscle Disorders

pyrazinamide has been researched along with Muscle Disorders in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"A 26-year-old man, who had started treatment for pulmonary tuberculosis, developed polyarthralgia, generalised myalgia, weakness, and elevated uric acid and creatine kinase levels."3.81Drug-induced myopathy in a patient with pulmonary tuberculosis. ( Shah, R; Venkatesan, P, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shah, R1
Venkatesan, P1
Fernández-Solà, J1
Campistol, JM1
Miró, O1
Garcés, N1
Soy, D1
Grau, JM1

Other Studies

2 other studies available for pyrazinamide and Muscle Disorders

ArticleYear
Drug-induced myopathy in a patient with pulmonary tuberculosis.
    BMJ case reports, 2015, Jul-15, Volume: 2015

    Topics: Adult; Antitubercular Agents; Arthralgia; Creatine Kinase; Humans; Male; Muscle Weakness; Muscular D

2015
Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:9

    Topics: Acute Disease; Adult; Antitubercular Agents; Cyclosporine; Drug Interactions; Female; Humans; Immuno

1996